Clinical Trial

Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of the planned study is to assess the prophylactic effect of intraoperative administration of a single dose of methylprednisolone 2 (mg/kg) in decreasing the incidence of postoperative acute kidney injury after cardiac surgeries with cardiopulmonary bypass.
Trial Details
NCT Number NCT06917859
Lead Sponsor Ain Shams University
Conditions Cardiopulmonary Bypass, AKI - Acute Kidney Injury
Enrollment 170 participants
Start Date 2025-02-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-09